Multicenter Randomized Controlled Trial Between Febuxostat and Allopurinol in Chronic Heart Failure Patients With Hyperuricemia

被引：0
|
作者：
Suzuki, Satoshi
Yoshihisa, Akiomi
Sato, Akihiko
Shimizu, Takeshi
Sato, Takamasa
Sakamoto, Nobuo
Nakazato, Kazuhiko
Tsuda, Tatsunori
Tsuda, Akihiro
Goto, Jun
Ishibashi, Toshiyuki
Konno, Ichiro
Yamaguchi, Osamu
Machii, Hirofumi
Nozaki, Naoki
Niizeki, Takeshi
Miyamoto, Takuya
Kubota, Isao
Takeishi, Yasuchika
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
14509
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CONVERSION FROM ALLOPURINOL TO FEBUXOSTAT IS BENEFIT FOR CKD PATIENTS WITH HYPERURICEMIA
    Kanai, Hidetoshi
    Harada, Kenji
    Tamura, Yasuhisa
    Kawai, Yasuhiro
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 138 - 138
  • [22] Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients
    Arrigo Francesco Giuseppe Cicero
    Eugenio Roberto Cosentino
    Masanari Kuwabara
    Daniela Degli Esposti
    Claudio Borghi
    Internal and Emergency Medicine, 2019, 14 : 949 - 956
  • [23] Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients
    Cicero, Arrigo Francesco Giuseppe
    Cosentino, Eugenio Roberto
    Kuwabara, Masanari
    Degli Esposti, Daniela
    Borghi, Claudio
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (06) : 949 - 956
  • [24] EFFECT OF FEBUXOSTAT VERSUS ALLOPURINOL ON HYPERURICEMIA AND PROGRESSION OF CHRONIC KIDNEY DISEASE
    Nagaraju, Shankar Prasad
    Attur, Ravindra Prabhu
    Rangaswamy, Dharshan
    Rao, Indu
    Rao, Srikanth Prasad
    Kaza, Sindhu
    Shenoy, Srinivas
    Saraf, Karan
    Bhojaraja, Mohan
    Ramaswamy, Ashok
    Laxminarayana, Sindhura Lakshmi Koulmane
    Kosuru, Srinivas
    Parthasarathy, Rajeevalochana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [25] Effect of Febuxostat versus Allopurinol on the Glomerular Filtration Rate and Hyperuricemia in Patients with Chronic Kidney Disease
    Nagaraju, Shankar Prasad
    Shenoy, Srinivas Vinayak
    Rao, Indu
    Prabhu, Ravindra Attur
    Rangaswamy, Dharshan
    Bhojaraja, Mohan V.
    Guddattu, Vasudeva
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (04) : 279 - 287
  • [26] RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND CHRONIC KIDNEY DISEASE: A META-ANALYSIS
    Edding, Sherida
    Cabral, Brian Michael
    Cating-Cabral, Monica Therese
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 565 - 565
  • [27] Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
    Tsuruta, Yuki
    Mochizuki, Toshio
    Moriyama, Takahito
    Itabashi, Mitsuyo
    Takei, Takashi
    Tsuchiya, Ken
    Nitta, Kosaku
    CLINICAL RHEUMATOLOGY, 2014, 33 (11) : 1643 - 1648
  • [28] RENOPROTECTIVE EFFECTS OF FEBUXOSTAT AND ALLOPURINOL IN PATIENTS WITH HYPERURICEMIA AND CHRONIC KIDNEY DISEASES: A META-ANALYSIS
    Edding, Sherida
    Cabral, Brian Michael
    Cating-Cabral, Monica Therese
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 14 - 14
  • [29] Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
    Liao, Zhimin
    Xu, Lei
    Wan, Bo
    Wang, Liping
    Zhao, Chengzhi
    Wu, Gang
    Xie, Rui
    EMERGENCY MEDICINE INTERNATIONAL, 2022, 2022
  • [30] Telemonitoring in Patients with Chronic Heart Failure: Multicenter Randomized Trial in Japan (Pilot Study)
    Mizukawa, Mariko
    Moriyama, Michiko
    Naka, Makiko
    Tomiyama, Miyuki
    Kobayashi, Shizue
    Kitagawa, Toshiro
    Hidaka, Takayuki
    Yasunobu, Yuji
    Morishima, Nobuyuki
    Kihara, Yasuki
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (10) : S144 - S144
12345